Pharma-Bio Serv, Inc.
PBSVUS売上高
$9M
百万USD
営業利益
$-1M
百万USD
純利益
$-0M
百万USD
ROE
-0.8%
最新FY
EPS
$-0.00
USD / 株
配当
-
USD / 株
業績推移
収益性
キャッシュフロー
財務状況
四半期業績
| 年度 | 期 | 売上高 | 純利益 | EPS |
|---|---|---|---|---|
| FY2021 | Q1 | $4M | $0M | - |
| FY2021 | Q2 | $5M | $0M | - |
| FY2021 | Q3 | $5M | $2M | - |
| FY2021 | FY | $20M | $-2M | - |
| FY2022 | Q1 | $5M | $0M | - |
| FY2022 | Q2 | $5M | $0M | - |
| FY2022 | Q3 | $5M | $0M | - |
| FY2022 | FY | $19M | $1M | - |
| FY2023 | Q1 | $4M | $0M | - |
| FY2023 | Q2 | $5M | $0M | - |
| FY2023 | Q3 | $5M | $1M | - |
| FY2023 | FY | $17M | $1M | - |
| FY2024 | Q1 | $2M | $-0M | - |
| FY2024 | Q2 | $2M | $-0M | - |
| FY2024 | Q3 | $2M | $-0M | - |
| FY2024 | FY | $10M | $-1M | $-0.03 |
| FY2025 | Q1 | $2M | $0M | $0.00 |
| FY2025 | Q2 | $2M | $0M | $0.00 |
| FY2025 | Q3 | $2M | $-0M | $0.01 |
| FY2025 | FY | $9M | $-0M | $-0.00 |
| FY2026 | Q1 | $2M | $0M | $0.00 |
| FY2026 | Q2 | $3M | $0M | $0.01 |
財務データ
| 指標 | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| 売上高 | - | - | $18M | $20M | $22M | $20M | $19M | $17M | $10M | $9M |
| 営業利益 | $-0M | $-1M | $-1M | $2M | $2M | $-4M | $1M | $1M | $-1M | $-1M |
| 純利益 | $-0M | $-1M | $1M | $2M | $2M | $-2M | $1M | $1M | $-1M | $-0M |
| 総資産 | $24M | $22M | $25M | $27M | $30M | $24M | $21M | $20M | $16M | $14M |
| 純資産 | - | - | - | - | - | - | - | - | - | - |
| 自己資本 | $22M | $21M | $20M | $21M | $23M | $19M | $17M | $16M | $14M | $12M |
| 営業CF | $1M | $-2M | $4M | $-2M | $2M | $1M | $1M | $2M | $-1M | $-0M |
| EPS | $-0.01 | $-0.06 | - | - | - | - | - | - | $-0.03 | $-0.00 |
| BPS | $0.94 | $0.90 | $0.88 | $0.90 | $0.99 | $0.82 | $0.72 | $0.70 | $0.60 | $0.52 |
| ROE | -1.2% | -6.8% | 6.3% | 10.1% | 9.0% | -11.0% | 6.1% | 8.1% | -5.7% | -0.8% |